Foley Hoag provides innovative, strategic legal services to public, private and government clients. We have premier capabilities in the life sciences, healthcare, technology, energy, professional services and private funds fields, and in cross-border disputes. The diverse experiences of our lawyers contribute to the exceptional senior-level service we deliver to clients.
The French Supreme Court's dismissal of the French Patent Office's appeal on January 31, 2024, marks a significant victory for research institutions.
United States
To print this article, all you need is to be registered or login on Mondaq.com.
The French Supreme Court's dismissal of the French Patent
Office's appeal on January 31, 2024, marks a significant
victory for research institutions. The patent term extension for
Bavencio, an immunotherapy treatment, will provide Dana-Farber
Cancer Institute with an additional five years of patent protection
and royalties.
Foley Hoag partners DeAnn Smith and Peter Sullivan advised
Dana-Farber on obtaining SPCs, while Martin Le Guerer represented
them in the Supreme Court. This decision follows the Paris Court of
Appeals' ruling, which was named 'Impact Case of the
Year' by Managing IP Europe in 2023.
French Supreme Court Grants Dana-Farber Cancer Institute 5-Year Patent Extension For Bavencio
United States
Contributor
Foley Hoag provides innovative, strategic legal services to public, private and government clients. We have premier capabilities in the life sciences, healthcare, technology, energy, professional services and private funds fields, and in cross-border disputes. The diverse experiences of our lawyers contribute to the exceptional senior-level service we deliver to clients.
